- Home
- TCRT vs VSME Comparison
TCRT vs VSME Comparison
Compare TCRT & VSME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- VSME
- Stock Information
- Founded
- TCRT 1998
- VSME 2013
- Country
- TCRT United States
- VSME Hong Kong
- Employees
- TCRT N/A
- VSME N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- VSME
- Sector
- TCRT Health Care
- VSME
- Exchange
- TCRT Nasdaq
- VSME Nasdaq
- Market Cap
- TCRT 3.8M
- VSME N/A
- IPO Year
- TCRT N/A
- VSME 2023
- Fundamental
- Price
- TCRT $5.00
- VSME $1.05
- Analyst Decision
- TCRT
- VSME
- Analyst Count
- TCRT 0
- VSME 0
- Target Price
- TCRT N/A
- VSME N/A
- AVG Volume (30 Days)
- TCRT 48.2K
- VSME 107.0K
- Earning Date
- TCRT 08-13-2025
- VSME 07-15-2025
- Dividend Yield
- TCRT N/A
- VSME N/A
- EPS Growth
- TCRT N/A
- VSME N/A
- EPS
- TCRT N/A
- VSME N/A
- Revenue
- TCRT $11,000.00
- VSME $8,248,108.00
- Revenue This Year
- TCRT $5,680,500.00
- VSME N/A
- Revenue Next Year
- TCRT N/A
- VSME N/A
- P/E Ratio
- TCRT N/A
- VSME N/A
- Revenue Growth
- TCRT 83.33
- VSME 3.22
- 52 Week Low
- TCRT $1.31
- VSME $0.51
- 52 Week High
- TCRT $6.99
- VSME $3.69
- Technical
- Relative Strength Index (RSI)
- TCRT 66.62
- VSME 55.79
- Support Level
- TCRT $4.38
- VSME $1.00
- Resistance Level
- TCRT $5.47
- VSME $1.13
- Average True Range (ATR)
- TCRT 0.68
- VSME 0.11
- MACD
- TCRT 0.07
- VSME -0.00
- Stochastic Oscillator
- TCRT 78.60
- VSME 70.21
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.